2019
DOI: 10.1111/jgh.14668
|View full text |Cite
|
Sign up to set email alerts
|

When repeated Helicobacter pylori therapies fail, what should we do?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Antibiotic resistance is increasing in recent years in a varying pattern among different countries. While clarithromycin resistance is markedly reported, fortunately, AMX resistance is still rare in many areas [3,7,8]. Accordingly, the failure of clarithromycin-based therapy in achieving a high cure rate in some patients shifted the attention to the use of AMX/MET with a PPI.…”
Section: Introductionmentioning
confidence: 99%
“…Antibiotic resistance is increasing in recent years in a varying pattern among different countries. While clarithromycin resistance is markedly reported, fortunately, AMX resistance is still rare in many areas [3,7,8]. Accordingly, the failure of clarithromycin-based therapy in achieving a high cure rate in some patients shifted the attention to the use of AMX/MET with a PPI.…”
Section: Introductionmentioning
confidence: 99%